No results for ‘’
Nectar Lifescience Ltd
₹11.44
(1.63%)
Sat, 20 Jun 2026, 02:27 pm
Health Technology
Pharmaceuticals: Major
24.5KNectar Lifescience Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 51.84 | 44.91 | 44.91 | 44.53 | 44.53 |
| FII | 0.60 | 0.52 | 0.62 | 0.81 | 1.65 |
| DII | 4.01 | 5.82 | 0.09 | 0.19 | 0.16 |
| Public | 43.52 | 48.73 | 54.37 | 54.44 | 53.65 |
| Government | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
Nectar Lifescience Ltd Shareholding Pattern
The Nectar Lifescience Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Nectar Lifescience Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.
Nectar Lifescience Ltd (NSE: NECLIFE, BSE: 532649) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Nectar Lifescience Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.
Nectar Lifescience Ltd Shareholding Pattern (Latest)
The latest Nectar Lifescience Ltd shareholding for Mar 2026 is:
- Promoters: 51.84%
- FII: 0.60%
- DII: 4.01%
- Public: 43.52%
- Government: 0.02%
Promoter holding in Nectar Lifescience Ltd has increased, indicating strong confidence from company promoters.
Nectar Lifescience Ltd Promoter Holding Trend
Promoter shareholding plays a crucial role in evaluating management confidence in Nectar Lifescience Ltd.
- Mar 2026: 51.84%
- Dec 2025: 44.91%
- Sept 2025: 44.91%
- Jun 2025: 44.53%
- Mar 2025: 44.53%
Promoter stake in Nectar Lifescience Ltd has increased, indicating strong long-term confidence.
Nectar Lifescience Ltd FII Shareholding Trend
Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Nectar Lifescience Ltd.
- Mar 2026: 0.60%
- Dec 2025: 0.52%
- Sept 2025: 0.62%
- Jun 2025: 0.81%
- Mar 2025: 1.65%
FII holding in Nectar Lifescience Ltd has increased recently, indicating rising foreign investor interest.
Nectar Lifescience Ltd DII Shareholding Trend
Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.
- Mar 2026: 4.01%
- Dec 2025: 5.82%
- Sept 2025: 0.09%
- Jun 2025: 0.19%
- Mar 2025: 0.16%
DII holdings remain stable, reflecting steady institutional participation.
Nectar Lifescience Ltd Public Shareholding Trend
Public shareholding represents retail and non-institutional investors.
- Mar 2026: 43.52%
- Dec 2025: 48.73%
- Sept 2025: 54.37%
- Jun 2025: 54.44%
- Mar 2025: 53.65%
Public holding remains stable with consistent retail participation.
Nectar Lifescience Ltd Government Holding
Government holding in Nectar Lifescience Ltd currently stands at 0.02%.
Government presence indicates institutional backing and regulatory confidence.
Nectar Lifescience Ltd Shareholding Analysis Summary
The Nectar Lifescience Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.
Nectar Lifescience Ltd shows strong promoter and domestic institutional confidence, which is positive for long-term investors.
Regular monitoring of the Nectar Lifescience Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.